A strategy of being profitably smart and socially good to provide affordable access to advanced biopharmaceuticals for global patient populations.
CONTACT
Group Companies
BIOCON’S BUSINESS MODEL IS WOVEN AROUND ITS COMMITMENT TO CORE VALUES
A motivation to enter niche areas where we perceive the potential to moderate costs and widen patient access.
A collaborative model that allows us to share risk and reward of drug development through research partnerships and extend our global footprint through local marketing alliances.
A business philosophy built around the core values of quality, affordability, reliability and innovation.
An unwavering commitment to stringent quality controls in compliance with best-in-class global standards.
A relentless focus on chronic disease spaces like diabetes, cancer and autoimmune / inflammation.
A portfolio approach focused on chronic disease segments and integrating well validated target-to-clinic-to-counter capabilities.
An obligation to develop affordable blockbuster drugs with the potential to benefit a billion patients.
